Malaria is perhaps the commonest disease you are likely to encounter in Ghana.
Malaria has been a major cause of poverty and low productivity accounting for about 32.5 percent of all OPD attendances and 48.8 percent of under five years admissions in the country.
Though Ghana has been making progress implementing its National Malaria Control Programme, there are still gaps in achieving their set targets.
Malaria is a life-threatening mosquito-borne blood disease caused by a Plasmodium parasite.
It is transmitted to humans through the bite of the Anopheles mosquito.
Once an infected mosquito bites a human, the parasites multiply in the host’s liver before infecting and destroying red blood cells.
In some places, malaria can be treated and controlled with early diagnosis. However, some countries lack the resources to do this effectively.
Currently, no vaccine is licensed for use in the United States or globally, although one is available in Europe.
Malaria was eliminated from the U.S. in the early 1950s, but between 1,500 and 2,000 cases still occur each year, mostly in those who have recently traveled to malaria-endemic areas.
What is malaria?
Malaria is passed on by the Anopheles mosquito.
Over 100 types of Plasmodium parasite can infect a variety of species. They replicate at different rates, and this affects how quickly the symptoms escalate, and the severity of the disease.
Five types of Plasmodium parasite can infect humans. They are found in different parts of the world. Some cause a more severe type of malaria than others.
Symptoms
Malaria symptoms can be classified into two categories: uncomplicated and severe malaria.
Uncomplicated malaria
This is diagnosed when symptoms are present, but there are no signs to indicate severe infection or dysfunction of the vital organs.
This form can become severe malaria if left untreated, or if the host has poor or no immunity.
Symptoms of uncomplicated malaria typically last 6 to 10 hours and recur every second day. Some strains of the parasite can have a longer cycle or cause mixed symptoms.
As symptoms resemble those of flu, they may be undiagnosed or misdiagnosed in areas where malaria is less common.
In uncomplicated malaria, symptoms progress as follows, through cold, hot, and sweating stages:
- a sensation of cold with shivering
- fever, headaches, and vomiting
- seizures sometimes occur in younger people with the disease
- sweats, followed by a return to normal temperature, with tiredness
In areas where malaria is common, many patients recognize the symptoms as malaria and treat themselves without visiting a doctor.
Severe malaria
In severe malaria, clinical or laboratory evidence shows signs of vital organ dysfunction.
Symptoms of severe malaria include:
- fever and chills
- impaired consciousness
- prostration, or adopting a prone position
- multiple convulsions
- deep breathing and respiratory distress
- abnormal bleeding and signs of anemia
- clinical jaundice and evidence of vital organ dysfunction
Severe malaria can be fatal without treatment.
Causes
Malaria happens when a bite from the female Anopheles mosquito infects the body with Plasmodium. Only the Anopheles mosquito can transmit malaria.
The successful development of the parasite within the mosquito depends on several factors, the most important being humidity and ambient temperatures.
When an infected mosquito bites a human host, the parasite enters the bloodstream and lays dormant within the liver.
The host will have no symptoms for an average of 10.5 days, but the malaria parasite will begin multiplying during this time.
The new malaria parasites are then released back into the bloodstream, where they infect red blood cells and multiply further. Some malaria parasites remain in the liver and are not released until later, resulting in recurrence.
An unaffected mosquito becomes infected once it feeds on an infected individual. This restarts the cycle.
Diagnosis
Early diagnosis is critical for a patient’s recovery.
Anyone showing signs of malaria should be tested immediately.
The World Health Organization (WHO) strongly advise confirmation of the parasite through microscopic laboratory testing or by a rapid diagnostic test (RDT), depending on the facilities available.
No combination of symptoms can reliably distinguish malaria from other causes, so a parasitological test is vital for identifying and managing the disease.
In some malaria-endemic areas, such as sub-Saharan Africa, the disease’s severity can cause mild immunity in a large proportion of the local population.
As a result, some people carry the parasites in their bloodstream but do not fall ill.
Treatment
Treatment aims to eliminate the Plasmodium parasite from the patient’s bloodstream.
Those without symptoms may be treated for infection to reduce the risk of disease transmission in the surrounding population.
Artemisinin-based combination therapy (ACT) is recommended by the WHO to treat uncomplicated malaria.
Artemisinin is derived from the plant Artemisia annua, better known as sweet wormwood. It is known for its ability to rapidly reduce the concentration of Plasmodium parasites in the bloodstream.
ACT is artemisinin combined with a partner drug. The role of artemisinin is to reduce the number of parasites within the first 3 days of infection, while the partner drugs eliminate the rest.
Expanding access to ACT treatment worldwide has helped reduce the impact of malaria, but the disease is becoming increasingly resistant to the effects of ACT.
In places where malaria is resistant to ACT, treatment must contain an effective partner drug.
The WHO has warned that no alternatives to artemisinin are likely to become available for several years.
Reference
https://www.medicalnewstoday.com/articles/150670.php
What do you think about this piece? Share your comment in the comment thread and share the story using the social media buttons above. Thank you.